Department of Oncology and Cancer Rehabilitation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
The First Clinical Medical College of Nanjing Medical University, Nanjing, Jiangsu, China.
J Nanobiotechnology. 2024 Feb 15;22(1):62. doi: 10.1186/s12951-024-02331-9.
A large number of Fusobacterium nucleatum (Fn) are present in colorectal cancer (CRC) tissues of patients who relapse after chemotherapy, and Fn has been reported to promote oxaliplatin and 5-FU chemoresistance in CRC. Pathogens such as bacteria and parasites stimulate exosome production in tumor cells, and the regulatory mechanism of exosomal circRNA in the transmission of oxaliplatin and 5-FU chemotherapy resistance in Fn-infected CRC remains unclear.
Hsa_circ_0004085 was screened by second-generation sequencing of CRC tissues. The correlation between hsa_circ_0004085 and patient clinical response to oxaliplatin/5-FU was analyzed. Exosome tracing experiments and live imaging systems were used to test the effect of Fn infection in CRC on the distribution of hsa_circ_0004085. Colony formation, ER tracking analysis and immunofluorescence were carried out to verify the regulatory effect of exosomes produced by Fn-infected CRC cells on chemotherapeutic resistance and ER stress. RNA pulldown, LC-MS/MS analysis and RIP were used to explore the regulatory mechanism of downstream target genes by hsa_circ_0004085.
First, we screened out hsa_circ_0004085 with abnormally high expression in CRC clinical samples infected with Fn and found that patients with high expression of hsa_circ_0004085 in plasma had a poor clinical response to oxaliplatin/5-FU. Subsequently, the circular structure of hsa_circ_0004085 was identified. Fn infection promoted hsa_circ_0004085 formation by hnRNP L and packaged hsa_circ_0004085 into exosomes by hnRNP A1. Exosomes produced by Fn-infected CRC cells transferred hsa_circ_0004085 between cells and delivered oxaliplatin/5-FU resistance to recipient cells by relieving ER stress. Hsa_circ_0004085 enhanced the stability of GRP78 mRNA by binding to RRBP1 and promoted the nuclear translocation of ATF6p50 to relieve ER stress.
Plasma levels of hsa_circ_0004085 are increased in colon cancer patients with intracellular Fn and are associated with a poor response to oxaliplatin/5-FU. Fn infection promoted hsa_circ_0004085 formation by hnRNP L and packaged hsa_circ_0004085 into exosomes by hnRNP A1. Exosomes secreted by Fn-infected CRC cells deliver hsa_circ_0004085 between cells. Hsa_circ_0004085 relieves ER stress in recipient cells by regulating GRP78 and ATF6p50, thereby delivering resistance to oxaliplatin and 5-FU.
大量的具核梭杆菌(Fn)存在于化疗后复发的结直肠癌(CRC)患者的组织中,并且已有报道称 Fn 可促进 CRC 对奥沙利铂和 5-FU 的耐药性。细菌和寄生虫等病原体可刺激肿瘤细胞产生外泌体,而 Fn 感染的 CRC 中外泌体 circRNA 在传递奥沙利铂和 5-FU 化疗耐药性中的调控机制尚不清楚。
通过对 CRC 组织的第二代测序筛选出 hsa_circ_0004085。分析 hsa_circ_0004085 与患者对奥沙利铂/5-FU 临床反应的相关性。通过外泌体示踪实验和活细胞成像系统检测 Fn 感染 CRC 对 hsa_circ_0004085 分布的影响。通过集落形成、ER 追踪分析和免疫荧光实验验证 Fn 感染 CRC 细胞产生的外泌体对化疗耐药性和 ER 应激的调节作用。通过 RNA 下拉、LC-MS/MS 分析和 RIP 实验探索 hsa_circ_0004085 对下游靶基因的调控机制。
首先,我们筛选出 Fn 感染 CRC 临床样本中异常高表达的 hsa_circ_0004085,并发现血浆中 hsa_circ_0004085 高表达的患者对奥沙利铂/5-FU 的临床反应较差。随后,鉴定了 hsa_circ_0004085 的环状结构。Fn 通过 hnRNP L 促进 hsa_circ_0004085 的形成,并通过 hnRNP A1 将 hsa_circ_0004085 包装成外泌体。Fn 感染的 CRC 细胞产生的外泌体将 hsa_circ_0004085 在细胞间传递,并通过减轻 ER 应激将奥沙利铂/5-FU 耐药性传递给受体细胞。hsa_circ_0004085 通过与 RRBP1 结合增强 GRP78 mRNA 的稳定性,并促进 ATF6p50 的核转位以减轻 ER 应激。
结直肠癌患者体内有胞内 Fn 时,血浆中 hsa_circ_0004085 的水平升高,且与奥沙利铂/5-FU 反应不良相关。Fn 通过 hnRNP L 促进 hsa_circ_0004085 的形成,并通过 hnRNP A1 将 hsa_circ_0004085 包装成外泌体。Fn 感染的 CRC 细胞分泌的外泌体在细胞间传递 hsa_circ_0004085。hsa_circ_0004085 通过调节 GRP78 和 ATF6p50 减轻 ER 应激,从而传递奥沙利铂和 5-FU 的耐药性。